Research Materials Generation

WuXi Biologics offers extensive research materials generation capabilities for the production of high-quality control antibodies, target proteins and antigens, and target and tool cell lines for immunization, bioassays, and candidate screening and other biologics discovery applications and research purposes. Additional R&D materials generation capabilities include: reagent labelling, protein engineering, protein bioconjugation, target cell line characterization, cell surface protein quantification, in-cell biotinylation, protein analytics and product or cell line stability assessment.

Target protein generation
Target cell line generation
Protein Engineering
Reagent Labeling

To learn more about our target protein generation capabilities and rapid, high-quality antibody and recombinant protein production platforms, Click here.

WuXi Biologics offers stable cell pool and stable cell line generation for membrane protein expression in mammalian cells. We have extensive experience in target cell line generation including challenging target proteins, such as GPCRs (G Protein-Coupled Receptors), ion channels, co-expressing cell lines, and reporter gene cell line generation

Stable cell pool: 7-10 weeks
Stable cell line: 10-15 weeks

Related services:

Cell surface protein quantitation
In-cell biotinylation

Cell line generation process and timeline：

Target cell line generation

WuXi Biologics offers antibody lead optimization services and customized protein engineering supported by structure-based design. Services include:

Antibody humanization (Learn More)
Antibody affinity maturation (Learn more)
Generation of soluble proteins with different tags
IgG antibodies with different isotypes
Engineering of bispecific antibodies (Learn more)
Engineering of fusion protein

WuXi Biologics can provide protein biotinylation, in-cell biotinylation, HRP conjugation and other protein labeling services.